FGFR3 and neoplasm: Notably, FGFR3 alterations were frequently correlated with the non-T cell inflamed tumor microenvironment which was associated with resistance to immunotherapy (50), besides, frequently altered FGFR3 was found to be enriched in the luminal UC subtype poorly responding to immunotherapy (51).